Shuichiro Fujinaga Selected Research

Shuichiro Fujinaga Research Topics

Disease

42	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2022 - 09/2005
8	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 06/2007
7	Proteinuria 05/2022 - 02/2004
5	Lupus Nephritis 10/2020 - 10/2005
5	Acute Kidney Injury (Acute Renal Failure) 12/2016 - 02/2005
4	Fibrosis (Cirrhosis) 01/2022 - 11/2009
4	Nephritis 01/2022 - 02/2004
4	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 03/2010
4	Nocturnal Enuresis (Bedwetting) 08/2020 - 12/2013
3	Chronic Renal Insufficiency 01/2022 - 08/2014
3	Purpura 01/2022 - 02/2004
3	Hematuria 01/2020 - 02/2006
2	Disease Progression 01/2022 - 02/2019
2	Ureteral Obstruction 01/2022 - 04/2014
2	Agammaglobulinemia (Hypogammaglobulinemia) 04/2020 - 06/2016
2	Fever (Fevers) 05/2019 - 01/2019
2	Neutropenia 01/2019 - 06/2016
2	Gastroenteritis 12/2016 - 02/2005
2	Infections 06/2016 - 06/2015
2	Birth Weight (Birth Weights) 12/2015 - 08/2014
2	Anemia 08/2014 - 08/2013
2	Renal hypouricemia 11/2013 - 02/2012
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 07/2009 - 06/2009
1	Down Syndrome (Down's Syndrome) 09/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Pierson syndrome 01/2021
1	Renal Tubular Acidosis (Distal Renal Tubular Acidosis) 11/2020
1	Serum Sickness 10/2020
1	Prolidase Deficiency 10/2020
1	Renal Insufficiency (Renal Failure) 11/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cytokine Release Syndrome 01/2018
1	Glomerulonephritis 01/2017
1	Lung Diseases (Lung Disease) 06/2015
1	Congenital Heart Defects (Congenital Heart Defect) 06/2015
1	Bronchitis 06/2015
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2014
1	Inflammation (Inflammations) 04/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2013
1	Polyuria 12/2013
1	Night Terrors (Sleep Terror) 12/2013
1	Posterior Leukoencephalopathy Syndrome 11/2013
1	Fabry Disease (Fabry's Disease) 01/2013
1	Urolithiasis 02/2012
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2010
1	Arthritis (Polyarthritis) 10/2010

Drug/Important Bio-Agent (IBA)

21	Rituximab (Mabthera)FDA Link 04/2021 - 07/2009
19	SteroidsIBA 01/2022 - 10/2005
18	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 02/2004
9	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2020 - 01/2007
7	mizoribineIBA 01/2022 - 10/2005
7	Methylprednisolone FDA LinkGeneric 01/2022 - 10/2005
7	Prednisolone (Predate)FDA LinkGeneric 01/2020 - 10/2005
5	CreatinineIBA 05/2022 - 08/2014
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 10/2005
4	Immunosuppressive Agents (Immunosuppressants)IBA 08/2017 - 10/2008
3	AntibodiesIBA 10/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 05/2022 - 08/2014
3	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2017 - 12/2013
3	Uric Acid (Urate)IBA 12/2016 - 02/2005
2	Pharmaceutical PreparationsIBA 01/2017 - 08/2013
2	Erythropoietin FDA Link 08/2014 - 08/2013
2	Darbepoetin alfa (Aranesp)FDA Link 08/2014 - 08/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2006 - 10/2005
1	HydrogenIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Laminin (Merosin)IBA 01/2021
1	Chloride-Bicarbonate AntiportersIBA 11/2020
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 11/2020
1	dirhodium tetraacetate (DRTA)IBA 11/2020
1	N- (4- ((5- (hydroxy(phenyl)methyl)pyrrolidin- 2- yl)methyl)phenyl)- 4- oxo- 4,6,7,8- tetrahydropyrrolo(1,2- a)pyrimidine- 6- carboxamideIBA 08/2020
1	AntigensIBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	ofatumumab FDA Link 01/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	Solifenacin Succinate FDA Link 01/2017
1	Immunoglobulin G (IgG)IBA 06/2016
1	PlasticsIBA 06/2015
1	Cystatin CIBA 08/2014
1	AlbuminsIBA 08/2014
1	AngiotensinogenIBA 08/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 05/2014
1	Renin InhibitorsIBA 04/2014
1	aliskiren FDA Link 04/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	TabletsIBA 12/2013
1	Yi-Gan SanIBA 12/2013
1	Biological ProductsIBA 04/2013
1	GalactosidasesIBA 01/2013
1	Calcium OxalateIBA 02/2012
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2010
1	Methotrexate (Mexate)FDA LinkGeneric 10/2010
1	Etanercept (Enbrel)FDA Link 10/2010

Therapy/Procedure

27	Therapeutics 01/2022 - 10/2005
4	Tonsillectomy 01/2020 - 03/2010
3	Peritoneal Dialysis 08/2014 - 06/2009
2	Renal Dialysis (Hemodialysis) 06/2015 - 08/2014
1	Continuous Passive Motion Therapy 02/2019
1	Intravenous Administration 08/2013